pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy

This study presents novel insights into the impact of ADT on the expression levels of pSTAT3<sup>Tyr705</sup> and pSTAT3<sup>Ser727</sup> in PCa. Cytoplasmic pSTAT3<sup>Ser727</sup> status of cancer-associated stromal cells in post-ADT samples may serve as an independent prognostic marker for OS and 5-year MFS, identifying prostate cancer patients prone to developing resistance to ADT.

Authors

Institutions

Publication Details

Journal
The Prostate
Published
2024-11-11
DOI
https://doi.org/10.1002/pros.24820
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy

Bruce J. Trock, Dominique Trudel, Rebecka Hellsten, Anders Bjartell et al.
1 citations
The Prostate
Prostate Cancer Treatment and Research
0.42
article

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy

Bruce J. Trock, Dominique Trudel, Rebecka Hellsten, Anders Bjartell, Agnieszka Krzyzanowska, Margareta Persson, Tuomas Mirtti, Piotr Białas, Tamae Kobayashi, Pekka Taimen, Fred Saad, Beatrice S. Knudsen, Angelo M. De Marzo, Isla P. Garraway, Felicia Marginean
article en
1 citations

Abstract

This study presents novel insights into the impact of ADT on the expression levels of pSTAT3<sup>Tyr705</sup> and pSTAT3<sup>Ser727</sup> in PCa. Cytoplasmic pSTAT3<sup>Ser727</sup> status of cancer-associated stromal cells in post-ADT samples may serve as an independent prognostic marker for OS and 5-year MFS, identifying prostate cancer patients prone to developing resistance to ADT.

The ProstateVol. 85(3)
Poznan University of Medical Sciences (PL), University of Helsinki (FI), Johns Hopkins University (US), University of Turku (FI), University of California, Los Angeles (US), Lund University (SE), University of Utah (US), Johns Hopkins Medicine (US), Helsinki University Hospital (FI), Turku University Hospital (FI), Skåne University Hospital (SE), Centre Hospitalier de l’Université de Montréal (CA), VA Greater Los Angeles Healthcare System (US), Sidney Kimmel Comprehensive Cancer Center (US), Hospital District of Helsinki and Uusimaa (FI), Université de Montréal (CA)
U.S. Department of Defense, Johns Hopkins University, Movember Foundation, Swedish Cancer Foundation, Cancerfonden, Lunds Universitet, Vetenskapsrådet, Kungliga Fysiografiska Sällskapet i Lund, Skånes universitetssjukhus, National Institutes of Health, Sidney Kimmel Comprehensive Cancer Center, Fonds de Recherche du Québec - Santé, National Cancer Institute, DOD Prostate Cancer Research Program
Good health and well-being
Openalex Percentile: Top 31%
Prostate Cancer Treatment and Research
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.